Search for: "Boehringer Ingelheim Pharmaceuticals"
Results 81 - 100
of 252
Sort by Relevance
|
Sort by Date
17 Nov 2014, 1:20 pm
The first such new blood thinner released was Pradaxa (dabigatran), a direct thrombin inhibitor by Boehringer Ingelheim. [read post]
23 Oct 2014, 3:27 pm
In the U.S., the drug industry spent $3.5 billion promoting its wares to consumers in 2012; in 2011, one manufacturer, Boehringer Ingelheim, spent $464 million advertising its blood thinner Pradaxa, a drug with demonstrable problems that have created legal problems for the company and considerable harm to patients. [read post]
23 Sep 2014, 4:38 am
The third post of the AIPPI Congress series features Annsley’s reports from the Pharma Day sessions, which focused on the hot topic of "Biosimilar pharmaceutical products". [read post]
19 Sep 2014, 5:50 pm
Michael Kompter (Senior Patent Counsel, IP Awareness and Enforcement, Boehringer Ingelheim, Germany) considered the issue of privilege from the standpoint of a civil law jurisdiction, as well as providing an in-house counsel’s perspective. [read post]
15 Sep 2014, 1:46 pm
Pradaxa is a competitor blood thinner from Boehringer Ingelheim. [read post]
5 Jun 2014, 7:06 am
Boehringer Ingelheim Pharmaceuticals, Inc., which was decided just a few months before I started my career in employment law. [read post]
3 Jun 2014, 4:41 pm
That same year, Boehringer Ingelheim Pharmaceuticals, Inc. made $1.5 billion in sales of Pradaxa. [read post]
30 May 2014, 8:13 am
German pharmaceutical company Boehringer Ingelheim has agreed to pay $650 million to settle thousands of consumer lawsuits involving its blood thinner medication Pradaxa. [read post]
3 Apr 2014, 5:00 am
This post discusses litigation holds. [read post]
31 Mar 2014, 7:58 am
Reuters reported than over 2,000 lawsuits in the US have been filed against German pharmaceutical firm Boehringer Ingelheim over its blockbuster blood thinning medicine Pradaxa (dabigatran etexilate). [read post]
19 Feb 2014, 10:43 am
2,000 Lawsuits Against Pradaxa Manufacturer Move Forward in the US German pharmaceutical manufacturer Boehringer Ingelheim reported on Thursday, February 13th, that the company faces more than 2,000 lawsuits in the United States in relation to its stroke prevention medication, Pradaxa, because the drug reportedly caused severe and even fatal bleeding. [read post]
13 Feb 2014, 6:00 am
District Court Judge David Herndon from the Southern District of Illinois imposed close to $1 million in punitive damages on defendants Boehringer Ingelheim International GMBH (“BII”) and Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
6 Feb 2014, 6:41 am
According to newly unsealed legal documents, Boehringer Ingelheim, the manufacturer of the blood-thinning drug Pradaxa were anxious that an internal research paper would damage drug sales and they suggested it should be suppressed. [read post]
28 Jan 2014, 11:53 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim Int’l. [read post]
25 Jan 2014, 9:43 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
15 Jan 2014, 5:43 am
Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
7 Jan 2014, 5:19 pm
Tradjenta (linagliptin) is manufactured by Eli Lilly and Boehringer Ingelheim and approved for sale in 2011. [read post]
5 Jan 2014, 5:43 pm
More than 1,700 personal injury lawsuits are pending against pharmaceutical company Boehringer Ingelheim in Illinois. [read post]
11 Dec 2013, 1:39 pm
Or are they taking one for the team for Boehringer Ingelheim? [read post]
25 Nov 2013, 1:44 pm
"Old" Warfarin Treatment (Posted by Tom Lamb at DrugInjuryWatch.com) A report published online in November 2013 by the medical journal JAMA: Internal Medicine, "A comparison of results of the US Food and Drug Administration's Mini-Sentinel Program with randomized clinical trials: The case of gastrointestinal tract bleeding with dabigatran", raises more drug-safety issues for the still relatively new blood thinner Pradaxa, from Boehringer Ingelheim Pharmaceuticals. [read post]
